James Legg

1.7k total citations
20 papers, 1.4k citations indexed

About

James Legg is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, James Legg has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Cell Biology and 7 papers in Immunology. Recurrent topics in James Legg's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Glycosylation and Glycoproteins Research (4 papers). James Legg is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Glycosylation and Glycoproteins Research (4 papers). James Legg collaborates with scholars based in United Kingdom, United States and Germany. James Legg's co-authors include Clare M. Isacke, Rick F. Thorne, Peter Herrlich, Helen Morrison, Fatima Banine, Helmut Ponta, David H. Gutmann, Larry S. Sherman, Carrie A. Haipek and Fiona M. Watt and has published in prestigious journals such as Genes & Development, Nature Cell Biology and Development.

In The Last Decade

James Legg

20 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Legg United Kingdom 11 697 673 279 245 231 20 1.4k
Jonathan M. Cooper United States 16 597 0.9× 774 1.2× 383 1.4× 312 1.3× 237 1.0× 18 1.7k
N Sato Japan 4 590 0.8× 574 0.9× 122 0.4× 307 1.3× 352 1.5× 8 1.1k
Leena Heiska Finland 10 442 0.6× 437 0.6× 113 0.4× 430 1.8× 297 1.3× 10 1.0k
Ichiko Saotome United States 18 1.1k 1.5× 1.2k 1.7× 364 1.3× 668 2.7× 194 0.8× 23 2.6k
Karine Raymond France 19 518 0.7× 799 1.2× 227 0.8× 69 0.3× 278 1.2× 28 1.5k
Ritsuo Nishiuchi Japan 21 346 0.5× 941 1.4× 224 0.8× 52 0.2× 622 2.7× 57 1.8k
Catherine Maingonnat France 23 604 0.9× 609 0.9× 361 1.3× 86 0.4× 121 0.5× 45 1.5k
Céline Pourreyron United Kingdom 20 275 0.4× 383 0.6× 299 1.1× 83 0.3× 140 0.6× 32 1.0k
Hongmin Tu Finland 18 322 0.5× 572 0.8× 140 0.5× 88 0.4× 420 1.8× 27 1.2k
Pierre Vaigot France 22 517 0.7× 841 1.2× 301 1.1× 35 0.1× 84 0.4× 51 1.7k

Countries citing papers authored by James Legg

Since Specialization
Citations

This map shows the geographic impact of James Legg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Legg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Legg more than expected).

Fields of papers citing papers by James Legg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Legg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Legg. The network helps show where James Legg may publish in the future.

Co-authorship network of co-authors of James Legg

This figure shows the co-authorship network connecting the top 25 collaborators of James Legg. A scholar is included among the top collaborators of James Legg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Legg. James Legg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chocarro, Luisa, Ester Blanco, Leticia Fernández, et al.. (2024). PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets. EMBO Molecular Medicine. 16(8). 1791–1816. 11 indexed citations
2.
Johnston, Colette M., et al.. (2024). Impact of tissue penetration and albumin binding on design of T cell targeted bispecific agents. Neoplasia. 48. 100962–100962. 4 indexed citations
3.
Johnston, Colette M., et al.. (2024). Design of Crosslinking Antibodies For T-Cell Activation: Experimental and Computational Analysis of PD-1/CD137 Bispecific Agents. The AAPS Journal. 26(4). 68–68. 1 indexed citations
4.
Lewandowska, Marta, Fevzi Demircioglu, Richard C. D. Brown, et al.. (2024). Abstract LB123: Conditionally active, therapeutic lymphotoxin beta receptor (LTBR) agonist bispecific antibodies for induction of tertiary lymphoid structures in the treatment of solid tumors. Cancer Research. 84(7_Supplement). LB123–LB123. 1 indexed citations
5.
Nessler, Ian, Eshita Khera, Qifeng Qiu, et al.. (2020). Increased Tumor Penetration of Single-Domain Antibody–Drug Conjugates Improves In Vivo Efficacy in Prostate Cancer Models. Cancer Research. 80(6). 1268–1278. 87 indexed citations
6.
7.
Borrok, M. Jack, Nadia Luheshi, Gareth Davies, et al.. (2015). Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding. mAbs. 7(4). 743–751. 58 indexed citations
8.
Luheshi, Nadia, et al.. (2015). Abstract 289: The combination of CD40 agonism and PD-L1 blockade enhances anti-tumor immunity in a mouse syngeneic orthotopic pancreatic tumor model. Cancer Research. 75(15_Supplement). 289–289. 3 indexed citations
9.
Luheshi, Nadia, Gareth Davies, & James Legg. (2014). Understanding the influence of the tumor microenvironment on macrophage responses to CD40 agonists. OncoImmunology. 3(2). e27615–e27615. 11 indexed citations
10.
Luheshi, Nadia, et al.. (2013). Abstract 1542: Th1 and Th2 cytokines determine how CD40 activation changes human macrophage function in vitro.. Cancer Research. 73(8_Supplement). 1542–1542. 1 indexed citations
11.
Eberlein, Cath, James Legg, Frank Gebhardt, et al.. (2013). Abstract 1616: Survivin regulates endothelial cell proliferation, survival and angiogenesis.. Cancer Research. 73(8_Supplement). 1616–1616. 1 indexed citations
12.
Luheshi, Nadia, Gareth Davies, Edmund Poon, et al.. (2013). Th1 cytokines are more effective than Th2 cytokines at licensing anti‐tumour functions in CD40‐activated human macrophages in vitro. European Journal of Immunology. 44(1). 162–172. 25 indexed citations
13.
Estrach, Soline, James Legg, & Fiona M. Watt. (2007). Syntenin mediates Delta1-induced cohesiveness of epidermal stem cells in culture. Journal of Cell Science. 120(16). 2944–2952. 55 indexed citations
14.
Thorne, Rick F., James Legg, & Clare M. Isacke. (2003). The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events. Journal of Cell Science. 117(3). 373–380. 193 indexed citations
15.
Legg, James, Uffe Birk Jensen, Simon Broad, Irene M. Leigh, & Fiona M. Watt. (2003). Role of melanoma chondroitin sulphate proteoglycan in patterning stem cells in human interfollicular epidermis. Development. 130(24). 6049–6063. 124 indexed citations
16.
Legg, James, et al.. (2002). A novel PKC-regulated mechanism controls CD44–ezrin association and directional cell motility. Nature Cell Biology. 4(6). 399–407. 192 indexed citations
17.
Morrison, Helen, Larry S. Sherman, James Legg, et al.. (2001). The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes & Development. 15(8). 968–980. 427 indexed citations
18.
Legg, James, et al.. (1998). Discrete Domains Within the Hyaluronan Receptor CD44 Regulate Membrane Localization and Cell Migration. Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication. 6(2-3). 149–156. 7 indexed citations
19.
Legg, James & Clare M. Isacke. (1998). Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Current Biology. 8(12). 705–708. 164 indexed citations
20.
Legg, James, et al.. (1953). Effect of Hydrogen‐Ion Concentration upon Growth and Development of Halogeton1. Agronomy Journal. 45(9). 450–451. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan M. Cooper Breakdown of academic impact, for papers by N Sato Breakdown of academic impact, for papers by Leena Heiska Breakdown of academic impact, for papers by Ichiko Saotome Breakdown of academic impact, for papers by Karine Raymond Breakdown of academic impact, for papers by Ritsuo Nishiuchi Breakdown of academic impact, for papers by Catherine Maingonnat Breakdown of academic impact, for papers by Céline Pourreyron Breakdown of academic impact, for papers by Hongmin Tu Breakdown of academic impact, for papers by Pierre Vaigot
Rankless by CCL
2026